ANAVEX LIFE SCIENCES Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (46)

Latest Posts

About This Stock More About This Stock
Alzheimer's Disease: 5 Stocks On Biotech Radars
Video By: Kevin Cook
Thursday, April 22, 2021 7:53 PM EDT
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other neurological and CNS diseases.
In this video: AVXL, JAZZ, BIIB, AXSM, SAVA
Watch
Top Picks 2020: Anavex
Article By: MoneyShow.com
Saturday, January 11, 2020 9:00 PM EDT
This little known, yet promising, bio-pharmaceutical company is worthy of a closer look.
In this article: AVXL
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EDT
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
5 Biomedical Stocks That Are Expected To Surge
Article By: Zacks Investment Research
Tuesday, June 27, 2017 5:01 PM EDT
Every investor struggles with balancing risk and reward when choosing their investments. Biomedical companies are known to offer large capital gains and growth prospects, yet they do not always come to fruition.
In this article: GERN, REGN, KDMN, ENZ, AVXL Also: JNJ
Read
E Anavex Announces Positive Phase 2a Results In Patients With Alzheimer's
Article By: Terry Chrisomalis
Monday, November 9, 2015 8:58 PM EDT
Today Anavex announced that it had obtained positive phase 2a results for its trial in treating patients with Alzheimer's.
In this article: AVXL
Read

Latest Tweets for $AVXL

No tweets yet!